A study of 639 Chinese women with postmenopausal osteoporosis previously showed that SOST polymorphic variant correlates with change in the BMD level in the lumbar spine and femoral neck after 12 months of alendronate therapy (P<0.05) [26]. This evidence concerns the gene SOST and postmenopausal osteoporosis.